BIOMAT Database Logo BIOMAT Database Logo

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. 1997

J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Department of Neurology, Hospital Universitario Doce de Octubre, Alcala de Henares, Spain.

We compared CSF and serum levels, and the CSF/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 34 patients with Parkinson's disease (PD) and 47 controls. CSF and serum vitamin E levels were correlate. The mean CSF and serum vitamin E levels, and the CSF/serum ratio of PD patients did not differ significantly between the groups. There was no influence of antiparkinsonian therapy on CSF vitamin E levels. CSF vitamin E levels did not correlate with age, age at onset, duration of the disease, scores of the Unified Parkinson Disease Rating Scale of the Hoehn and Yahr staging in the PD group. These results suggest that CSF vitamin E concentrations are unrelated with the risk for PD.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
May 1992, Neurology,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
alpha-Tocopherol concentrations in equine serum and cerebrospinal fluid after vitamin E supplementation.
March 2010, The Veterinary record,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.
October 1996, Neurology,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Vitamin E (alpha-tocopherol).
February 1990, Neonatal network : NN,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Alpha tocopherol (vitamin E) in obliterative arterial disease.
July 1951, International record of medicine and general practice clinics,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Vitamin "E" (dl-alpha tocopherol)--(d-alpha tocopherol).
July 1969, Journal of maxillofacial orthopedics,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Cerebrospinal fluid choline levels in Parkinson's disease.
July 1993, Annals of neurology,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Vitamin E potency of alpha-tocopherol and alpha-tocopherol esters.
September 1949, The Journal of biological chemistry,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Cerebrospinal fluid levels of alpha-synuclein in PARKINSON'S disease: Another long and winding road.
April 2018, Parkinsonism & related disorders,
J A Molina, and F de Bustos, and F J Jiménez-Jiménez, and J Benito-León, and M Ortí-Pareja, and T Gasalla, and A Tallón-Barranco, and J A Navarro, and J Arenas, and R Enríquez-de-Salamanca
Plasma levels of vitamin E in Parkinson's disease.
January 1995, Journal of neural transmission. Supplementum,
Copied contents to your clipboard!